Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin + Ipamorelin Blend: Quality Comparison

FDA-registered 503B facility Third-party HPLC + mass spec per batch 85–92% report measurable VAT reduction $420–$680 Highest consistency. Trackable batch numbers allow verification State-licensed compounding pharmacy (503A) Varies. Some test per batch, others

This comparison does not assign a generated winner or score.

  • FDA-registered 503B facility
  • Third-party HPLC + mass spec per batch
  • 85–92% report measurable VAT reduction
  • $420–$680
  • Highest consistency. Trackable batch numbers allow verification
  • State-licensed compounding pharmacy (503A)
  • Varies. Some test per batch, others rely on raw material COAs
  • 65–78% report expected results
  • $320–$540
  • Quality inconsistent. Success correlates with pharmacy's testing rigor
  • Overseas research chemical suppliers
  • Rarely verified. User-initiated testing via Janoshik shows 40% failure rate
  • 35–55% report any effect
  • $180–$320
  • Unacceptable risk. Contamination, wrong peptide, or underdosed product common
  • Lyophilised peptides from verified research suppliers
  • COA with each batch. HPLC, mass spec, sterility testing standard
  • 88–94% consistency in community reports
  • $380–$620
  • Research-grade purity with transparent testing. Every batch traceable
More references

Related material